Mintu Turakhia, M.D., M.S.,

Mintu Turakhia, M.D., M.S.,, Chief Medical Officer and Chief Scientific Officer

Dr. Turakhia, who joined as CMO and CSO in 2022, is an internationally recognized cardiac electrophysiologist and leader in digital health and heart rhythm care. He is Professor of Medicine (on leave) at the Stanford University School of Medicine. Trained in computer science, medicine, biostatistics, and research, he brings over 20 years of experience in patient care, outcomes research and trials, data science and artificial intelligence, medical device regulation, and the creation and commercialization of digital health products.

As Co-Founder of the Stanford Center for Digital Health, he has led several large-scale trials of digital health tools and wearables for heart disease, including the landmark Apple Heart Study. In academic and industry roles, he has led teams to build and commercialize software-enabled disease management and remote patient monitoring programs for heart disease with several recent exits. An elected member of the American Society of Clinical Investigation, Dr. Turakhia has authored over 300 publications and has received over $40 million in research funding. Over the last 20 years, he has had several dozen leadership and clinical practice guideline author roles in the Heart Rhythm Society, American Heart Association, American College of Cardiology, and European Society of Cardiology. He completed his bachelor’s degree at the University of California (UC) Berkeley, MD and master’s degrees at UCSF, and clinical training at Harvard’s Brigham & Women’s Hospital and UCSF. For 14 years, he served as Chief of Cardiac Electrophysiology at the VA Palo Alto Health Care System, where he still practices and performs catheter ablation and device implantation.

Email Alerts

Sign up to receive e-mail alerts whenever iRhythm posts new information to the site.